Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma

International Journal of Medical Sciences

Volumn 10, Issue 5, 2013, Pages 585-592

  Zhang, Jing ^a   Liu, Yang ^a   Liu, Zheng ^a   Wang, Xiao Ming ^a   Yin, De Tao ^a   Zheng, Li Li ^a   Zhang, De Yan ^a   Lu, Xiu Bo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Bioinformatics; Microarray; MicroRNA; Papillary thyroid carcinoma; qRT PCR

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 130A; MICRORNA 146B; MICRORNA 181A; MICRORNA 181C; MICRORNA 182; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 31; MICRORNA 335; MICRORNA 34A; MICRORNA 374B; MICRORNA 375; MICRORNA 486; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER STAGING; CASE REPORT; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC DIFFERENCE; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; THYROID CARCINOMA; UPREGULATION;

BIOINFORMATICS.; MICROARRAY; MICRORNA; PAPILLARY THYROID CARCINOMA; QRT-PCR;

AGED; APOPTOSIS; CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 84875341825     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5794     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012; 62:10-29.
2. De la Chapelle A, Jazdzewski K. MicroRNAs in thyroid cancer. J Clin Endocrinol Metab. 2011;96:3326-36.
3. Vriens MR, Weng J, Suh I, et al. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer. 2012; 118:3426-32.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell. 2012;116:281-297.
5. Esmerina TL, Jean-Jacques M, George AC. Expression and function of micro RNAs in immune cells during normal or disease state. Int. J. Med. Sci. 2008; 5: 73-79.
6. Cheng AM, Byrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005; 33:1290-1297.
7. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999-3004.
8. Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
9. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006;6:857-866.
10. Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-55.
11. Sobin LH, Wittekind C. The International Union against Cancer (UICC) TNM classification of malignant tumors, 6th edition. New York: Wiley Liss: 2002; 22-26.
12. Zhu Q, Hong A, Sheng N, Zhang X, et al. MicroParaflo biochip for nucleic acid and protein analysis. Methods Mol Biol. 2007; 382:287-312.
13. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193.
14. Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006;38: 14-19.
15. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441-450.
16. Akama T, Sue M, Kawashima A, et al. Identification of microRNAs that mediate thyroid cell growth induced by TSH. Mol Endocrinol. 2012;26:493-501.
17. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis. 2007;28:2-12.
18. Sarah SR. MicroRNA: Stage-specific signatures. Nature Reviews Cancer. 2009;:766-67.
19. Nikiforova MN, Chiosea SI, Nikiforov YE. MicroRNA Expression Profiles in Thyroid Tumors. Endocr Pathol. 2009;20: 85-91.
20. He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA.2005; 102:19075-19080.
21. Iorio MV, Ferracin M, Liu CG, et al. MicroRNAs gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065-7070.
22. Gillespie JW, Nasir A, Kaiser HE. Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review. In Vivo. 2000;14:139-140.
23. Huang Y, De la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer. 2003;104:735-744.
24. Tetzlaff MT, Liu A, Xu X, et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol. 2007; 18: 163-173.
25. Visone R, Russo L, Pallante P, et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer. 2007;14:791-798.
26. Chou CK, Chen RF, Chou FF, et al. miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation. Thyroid. 2010;20:489-94.
27. Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene. 2012;31:1910-22.
28. Mingfeng S, Xiaoke Z, Sihan W, et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer. 2011;10: 59
29. Scarola M, Schoeftner S, Schneider C, et al. miR-335 Directly Targets Rb1 (pRb/p105) in a Proximal Connection to p53-Dependent Stress Response. Cancer Res. 2010;70:6925-33.
30. Tomé M, López-Romero P, Albo C, et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 2011; 18: 985-995.
31. Sathyan P, Golden HB, Miranda RC. Competing Interactions between Micro-RNAs Determine Neural Progenitor Survival and Proliferation after Ethanol Exposure: Evidence from an Ex Vivo Model of the Fetal Cerebral Cortical Neuroepithelium. J Neurosci. 2007;27: 8546-57.
32. Eszlinger M, Krohn K, Hauptmann S, et al. Perspectives for improved and more accurate classification of thyroid epithelial tumors. J Clin Endocrinol Metab. 2008;93:3286-3294.